
NVIDIA expands AI radiology efforts with new software capabilities and partnerships
The company is hoping to boost the adoption of AI in medical imaging with new software development kits and deals with Ohio State University and the NIH.
The company is hoping to boost the adoption of AI in medical imaging with new software development kits and deals with Ohio State University and the NIH.
During a panel at the MedCity INVEST Twin Cities conference leaders from the payer, provider and investor spaces spoke about how to actually drive adoption of AI tools in the clinical system.
The company introduced its Clara platform, a combination of a new GPU-based hardware architecture and a software development kit allowing third-party developers to build applications for medical imaging.
San Francisco-based firm, focusing on Parkinson's disease and amyotrophic lateral sclerosis, has raised $36 million to date.
Recursion plans to start study of machine learning-discovered drug REC-994 later this year, CEO says.